What the clinical trials show
The strongest evidence for Mounjaro weight loss comes from the SURMOUNT clinical trial programme conducted by Eli Lilly. These large-scale, randomised, double-blind trials are the gold standard for evaluating medication effectiveness. In SURMOUNT-1, which enrolled 2,539 adults with obesity or overweight (without type 2 diabetes), participants taking tirzepatide achieved remarkable results over 72 weeks:
- 5mg dose: Average weight loss of 15.0% of body weight (approximately 15.7kg)
- 10mg dose: Average weight loss of 19.5% of body weight (approximately 20.9kg)
- 15mg dose: Average weight loss of 20.9% of body weight (approximately 22.5kg)
- Placebo group: Average weight loss of just 3.1%
Results at each dose level
Mounjaro is prescribed in a titration schedule that starts at 2.5mg and can increase up to 15mg. Understanding what to expect at each stage helps set realistic expectations.
- 2.5mg (weeks 1-4): This is the introductory dose designed to help your body adjust. Most people lose 1-3kg during this phase, though some may not lose any weight. This is normal and expected.
- 5mg (weeks 5-8): This is the first therapeutic dose. Appetite suppression becomes more noticeable, and most users begin to see consistent weight loss of 0.5-1kg per week.
- 7.5mg to 10mg (weeks 9-16): Weight loss typically accelerates. Many UK users report losing 1-1.5kg per week during this period. This is often described as the phase where Mounjaro "really starts working."
- 12.5mg to 15mg (weeks 17+): The highest doses produce the strongest appetite suppression. Weight loss may continue at a similar rate or gradually slow as you approach a lower body weight.
Timeline: when to expect results
One of the most common questions from UK users starting Mounjaro is how quickly they will see results. Based on clinical trial data and real-world reports, here is a general timeline.
During weeks 1-4 (2.5mg starting dose), changes are subtle. You may notice a slight reduction in appetite and lose 1-3kg, mostly from reduced calorie intake as your appetite decreases. Some people notice no change at all during this phase.
By weeks 4-8 (5mg dose), most users report a meaningful reduction in food cravings and portion sizes. Weight loss becomes more visible, and many people have lost 4-7kg by this point. Clothes may start to feel looser.
At weeks 8-16 (7.5mg-10mg), weight loss is typically well-established. Many users have lost 8-14kg by week 16. This is the period where friends and family often start to notice the change.
From weeks 16-36 (maintenance doses), weight loss continues but may gradually slow. The rate of loss is influenced heavily by diet, physical activity, and adherence to the injection schedule.
By week 72 (approximately 18 months), clinical trial participants had achieved their maximum average weight loss. However, most of the significant loss occurred in the first 9-12 months, with the remaining months focused on continued gradual loss and weight maintenance.
Factors that affect your results
Individual results on Mounjaro vary considerably. Several factors influence how much weight you will lose and how quickly:
- Starting weight: People with a higher starting BMI tend to lose more weight in absolute terms (kilograms), though the percentage loss is often similar across BMI categories.
- Diet quality: Mounjaro reduces appetite, but the foods you choose still matter. A balanced diet rich in protein, vegetables, and whole grains will support better results than relying on appetite suppression alone. See our guide on foods to eat and avoid on Mounjaro.
- Physical activity: Regular exercise, even moderate walking, enhances weight loss and helps preserve muscle mass during rapid weight loss.
- Dose adherence: Missing injections or inconsistent dosing will reduce the effectiveness of treatment. Take your injection on the same day each week.
- Sleep and stress: Poor sleep and chronic stress can interfere with weight loss by affecting hunger hormones and metabolism.
- Metabolic factors: Individual metabolic rate, hormonal conditions (such as thyroid disorders or PCOS), and genetics all play a role in how your body responds to treatment.
- Medications: Some medications, including certain antidepressants, corticosteroids, and insulin, can promote weight gain and may reduce the effectiveness of Mounjaro.
How UK results compare to clinical trials
Real-world results in the UK may differ from clinical trial outcomes, and it is important to understand why. Clinical trials provide a controlled environment with regular monitoring, dietary counselling, and strict adherence protocols. In real-world use, adherence tends to be lower, dietary support may be limited, and people may miss doses or stop treatment earlier.
That said, many UK users report results that are broadly consistent with or close to the trial data. Online communities and pharmacy follow-up data suggest that weight loss of 10-20% of body weight over 6-12 months is common among users who adhere to their treatment plan and make dietary adjustments.
Some users report exceeding the trial averages, particularly those who combine Mounjaro with structured exercise programmes and significant dietary changes. Others may see more modest results, especially if they are on lower doses or have factors that limit weight loss.
The key takeaway is that Mounjaro is not a magic solution. It is a powerful tool that works best when combined with lifestyle changes. The clinical trial results are achievable, but they require commitment to the full treatment plan.
Maximising your Mounjaro results
To get the best possible results from Mounjaro, UK prescribers and clinical guidelines recommend the following strategies:
- Prioritise protein: Aim for at least 1.2-1.6g of protein per kilogram of your target body weight daily. This helps preserve lean muscle mass during weight loss.
- Stay hydrated: Drink at least 2 litres of water per day. Dehydration can cause fatigue, headaches, and constipation, all of which are also potential side effects of the medication.
- Move regularly: Aim for at least 150 minutes of moderate activity per week. This does not need to be intense exercise; brisk walking counts.
- Track your progress: Weigh yourself weekly at the same time and under the same conditions. Look at trends over weeks, not daily fluctuations.
- Attend follow-up consultations: Regular check-ins with your prescriber allow for dose adjustments and early identification of any issues.
- Be patient during the titration phase: The 2.5mg and early 5mg doses are about adjusting, not about dramatic weight loss. Give the medication time to work.